CoChat

Senescence and Inflammatory Markers for Predicting Clinical Progression in Parkinson’s Disease: The ICICLE-PD Study

Open access
Martin-Ruiz, Carmen, Williams-Gray, Caroline H., Yarnall, Alison J., Boucher, John J., Lawson, Rachael A., Wijeyekoon, Ruwani S., Barker, Roger A., Kolenda, Claire, Parker, Craig, Burn, David J., Von Zglinicki, Thomas, Saretzki, Gabriele · 2019 · Journal of Parkinson’s Disease
Cited by 58

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Background: Cognitive decline is a frequent complication of Parkinson’s disease (PD) and the identification of predictive biomarkers for it would help in its management. Objective: Our aim was to analyse whether senescence markers (telomere length, p16 and p21) or their change over time could help to better predict cognitive and motor progression of newly diagnosed PD patients. We also compared these senescence markers to previously analysed markers of inflammation for the same purpose. Methods: This study examined the association of blood-derived markers of cell senescence and inflammation with motor and cognitive function over time in an incident PD cohort (the ICICLE-PD study). Participants (154 newly diagnosed PD patients and 99 controls) underwent physical and cognitive assessments over 36 months of follow up. Mean leukocyte telomere length and the expression of senescence markers p21 and p16 were measured at two time points (baseline and 18 months). Additionally, we selected five inflammatory markers from existing baseline data. Results: We found that PD patients had shorter telomeres at baseline and 18 months compared to age-matched healthy controls which also correlated to dementia at 36 months. Baseline p16 levels were associated with faster rates of motor and cognitive decline over 36 months in PD cases, while a simple inflammatory summary score at baseline best predicted cognitive score over this same time period in PD patients. Conclusion: Our study suggests that both inflammatory and senescence markers (p16) are valuable predictors of clinical progression in PD patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3233/jpd-191724

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Research works printed but not linked: 45

  1. 10.1001/archneur.60.3.387 · DOI · Paper page
  2. 10.1212/01.wnl.0000242630.52203.8f · DOI · Paper page
  3. 10.1136/jnnp-2013-305277 · DOI · Paper page
  4. 10.1002/mds.20216 · DOI · Paper page
  5. 10.1212/01.WNL.0000036610.36834.E0 · DOI · Paper page
  6. 10.1016/j.parkreldis.2016.04.009 · DOI · Paper page
  7. 10.1002/gps.4623 · DOI
  8. 10.1002/ana.20869 · DOI · Paper page
  9. 10.1111/ene.12252 · DOI
  10. 10.1002/mds.21867 · DOI · Paper page
  11. 10.1093/ageing/aft036 · DOI
  12. 10.1016/j.neurobiolaging.2008.07.012 · DOI
  13. 10.1016/j.neurobiolaging.2009.12.006 · DOI · Paper page
  14. 10.1016/j.neulet.2011.01.041 · DOI
  15. 10.1016/j.neurobiolaging.2010.11.013 · DOI
  16. 10.1001/archneurol.2012.1541 · DOI · Paper page
  17. 10.1186/1471-2318-10-62 · DOI
  18. 10.3109/01677063.2011.651665 · DOI
  19. 10.1007/s12603-010-0275-7 · DOI
  20. 10.1371/journal.pone.0113387 · DOI · Paper page
  21. 10.1093/gerona/glq125 · DOI
  22. 10.1093/gerona/63.5.467 · DOI
  23. 10.1016/j.neurobiolaging.2011.05.022 · DOI
  24. 10.1016/j.mehy.2009.02.047 · DOI
  25. 10.1378/chest.15-0645 · DOI
  26. 10.1002/mds.26563 · DOI · Paper page
  27. 10.3389/fphys.2018.00706 · DOI · Paper page
  28. 10.1016/j.arr.2015.11.006 · DOI · Paper page
  29. 10.1212/WNL.0b013e31827deb74 · DOI · Paper page
  30. 10.1212/WNL.0000000000000066 · DOI · Paper page
  31. 10.1136/jnnp.55.3.181 · DOI · Paper page
  32. 10.1016/0022-3956(75)90026-6 · DOI · Paper page
  33. 10.1111/j.1532-5415.2005.53221.x · DOI · Paper page
  34. 10.1212/WNL.17.5.427 · DOI · Paper page
  35. 10.1002/mds.23429 · DOI · Paper page
  36. 10.1002/mds.27813 · DOI
  37. 10.1002/ajmg.b.32575 · DOI
  38. 10.1016/j.neurobiolaging.2008.05.016 · DOI
  39. 10.1186/s12868-017-0367-y · DOI
  40. 10.1186/s12974-018-1206-5 · DOI
  41. 10.1016/j.neulet.2012.03.093 · DOI
  42. 10.1111/j.1474-9726.2009.00489.x · DOI · Paper page
  43. 10.1186/s12974-017-0935-1 · DOI · Paper page
  44. 10.1001/jamaneurol.2016.2742 · DOI · Paper page
  45. 10.1007/s12035-017-0404-y · DOI

Cited by

See all 58

Metadata

Authors
Martin-Ruiz, C., Williams-Gray, C. H., Yarnall, A. J., Boucher, J. J., Lawson, R. A., Wijeyekoon, R. S., Barker, R. A., Kolenda, C., Parker, C., Burn, D. J., Von Zglinicki, T., & Saretzki, G.
Venue
Journal of Parkinson’s Disease
Published
2019-12-16
Volume
10
Issue
1
Pages
193-206
ISSN
  • 1877-7171 (ISSN-L)
  • 1877-718X
OpenAlex
W2980634970
Cited by
58
References
23
FWCI
3.71
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Senescence and Inflammatory Markers for Predicting Clinical Progression in Parkinson’s Disease: The ICICLE-PD Study. https://app.cochat.ai/papers/10.3233/jpd-191724
The paper
Martin-Ruiz, C., Williams-Gray, C. H., Yarnall, A. J., Boucher, J. J., Lawson, R. A., Wijeyekoon, R. S., Barker, R. A., Kolenda, C., Parker, C., Burn, D. J., Von Zglinicki, T., & Saretzki, G. (2019). Senescence and Inflammatory Markers for Predicting Clinical Progression in Parkinson’s Disease: The ICICLE-PD Study. Journal of Parkinson’s Disease. https://doi.org/10.3233/jpd-191724

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.